+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
From
From
From
From
Bleeding Disorder Drugs Market - Global Strategic Business Report - Product Thumbnail Image

Bleeding Disorder Drugs Market - Global Strategic Business Report

  • Report
  • February 2026
  • 488 Pages
  • Global
From
From
From
From
Rheumatology Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Rheumatology Therapeutics - Global Strategic Business Report

  • Report
  • February 2026
  • 196 Pages
  • Global
From
Monoclonal Antibodies Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Monoclonal Antibodies Market - Forecasts from 2022 to 2027

  • Report
  • December 2022
  • 142 Pages
  • Global
From
From
Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
Loading Indicator